| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.5 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.5 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.12 | 0.5 |